The beginning of a new era in the field of percutaneous valvular interventions (PARTNER 3 and Evolut Low Risk trials) - KIVIRID

The beginning of a new era in the field of percutaneous valvular interventions (PARTNER 3 and Evolut Low Risk trials)

Authors: Dariusz Dudek

Published: 2019-08-15

DOI: 10.1093/cvr/cvz186

Source: Full article

Abstract

No abstract found.